ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

MRUS Merus NV

47.02
2.11 (4.70%)
02 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Merus NV MRUS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
2.11 4.70% 47.02 08:53:21
개장가 저가 고가 종가 전일 종가
45.20 45.00 47.88 47.02 44.91
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/04/202401:00GLOBEMerus Presents Preclinical Data Demonstrating Efficacy of..
03/04/202421:00GLOBEMerus to Participate in a Fireside Chat at the 23rd Annual..
06/03/202422:15EDGAR2Form 8-K - Current report
06/03/202422:00BWGilead and Merus Announce Collaboration to Discover Novel..
06/03/202406:30GLOBEMerus Announces Publication of an Abstract for Presentation..
04/03/202422:00GLOBEMerus to Participate in a Fireside Chat at the Leerink..
29/02/202406:55EDGAR2Form S-3ASR - Automatic shelf registration statement of..
29/02/202406:15GLOBEMerus Announces Financial Results for the Fourth Quarter and..
15/02/202406:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/01/202422:00GLOBEMerus to Participate in Upcoming Investor Conferences
21/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202307:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202309:29EDGAR2Form 144 - Report of proposed sale of securities
13/12/202306:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202310:40GLOBEMerus Presents Interim Data on MCLA-129 at ESMO Asia..
02/12/202300:47EDGAR2Form 144 - Report of proposed sale of securities
27/11/202301:05GLOBEMerus Announces Publication of Abstracts on MCLA-129 for..
03/11/202305:12GLOBEMerus Announces Financial Results for the Third Quarter 2023..
03/11/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:00GLOBEMerus to Participate in Upcoming Investor Conferences
23/10/202320:30GLOBEMerus’ Zeno Interim Data Continues to Demonstrate Robust and..
16/10/202308:58GLOBEMerus Announces Business Update Conference Call
12/10/202305:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202305:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202322:32GLOBEMerus Announces Abstracts Accepted for Presentation at the..
31/08/202321:00GLOBEMerus to Participate in Upcoming Investor Conferences
12/08/202305:01EDGAR2Form 8-K - Current report
11/08/202322:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/08/202310:53GLOBEMerus Announces Pricing of Public Offering of Common Shares
10/08/202305:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/08/202305:01GLOBEMerus N.V. Announces Proposed Public Offering of Common..
08/08/202305:26GLOBEMerus Announces Financial Results for the Second Quarter..
08/08/202305:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/07/202321:00GLOBEMerus Announces Two Clinical Abstracts on Zenocutuzumab..
06/07/202305:01GLOBEZenocutuzumab (Zeno) granted second Breakthrough Therapy..
30/06/202305:30GLOBEZenocutuzumab (Zeno) granted Breakthrough Therapy..
15/06/202320:47GLOBEMerus Appoints Life Sciences Strategic and Financial..
31/05/202321:00GLOBEMerus to Participate in a Fireside Chat at the Jefferies..
05/05/202305:25GLOBEMerus Announces Financial Results for the First Quarter 2023..

최근 히스토리

Delayed Upgrade Clock